Baseline predictors of visual response and treatment burden after ranibizumab therapy in macular edema secondary to retinal vein occlusion.

Front Med (Lausanne) · 2026 · PMC13290520 · PMID 42359082

Europe PMC DOI

hedged sentences

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

a weak trendp = 0.086so close (0.05 < p ≤ 0.1)

CST showed a borderline positive correlation with injection number (rho = 0.215, p = 0.055), and SII also showed a weak trend (rho = 0.193, p = 0.086).

also in 1,404 other papers

borderline significanceno p-value reported

NLR ( p = 0.057), SII ( p = 0.059), and EZ/ELM disruption ( p = 0.061) showed borderline significance.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.